Fast food consumption and risk of non-alcoholic fatty liver disease: a systematic review and meta-analysis
- PMID: 40809752
- PMCID: PMC12343633
- DOI: 10.3389/fpubh.2025.1600826
Fast food consumption and risk of non-alcoholic fatty liver disease: a systematic review and meta-analysis
Abstract
Background: Non-alcoholic fatty liver disease (NAFLD) is a global health issue, with fast food consumption hypothesized as a risk factor. This meta-analysis aimed to explore the relationship between fast food intake and NAFLD.
Methods: This review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines. A comprehensive search was conducted across PubMed, Web of Science, Scopus, and Embase from inception to February 28, 2025. A total of nine eligible observational studies involving 169,771 participants were included. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using random-effects models.
Results: A higher consumption of fast food was significantly associated with a 55% increased risk of NAFLD (OR = 1.55, 95% CI: 1.51-1.59, p < 0.001, I2 = 15.6%). Moreover, fast food intake was linked to a 37% higher risk of obesity (OR = 1.37, 95% CI: 1.27-1.49, p < 0.001, I2 = 54.2%), a key metabolic factor in NAFLD pathogenesis. Sensitivity analysis confirmed the robustness of these associations, with no significant evidence of publication bias.
Conclusion: Fast food consumption is positively associated with NAFLD and obesity. Heterogeneity highlights the need for standardized methods in future large-scale studies to validate these findings and inform preventive strategies.
Keywords: fast food; meta-analysis; non-alcoholic fatty liver disease; obesity; systematic review.
Copyright © 2025 He, Wang and Weng.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures







Similar articles
-
The Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Non-Alcoholic Liver Diseases: NAFLD, NASH, Fibrosis, Cirrhosis-A Systematic Review, Meta-Analysis and Meta-Regression.Nutrients. 2022 Dec 9;14(24):5261. doi: 10.3390/nu14245261. Nutrients. 2022. PMID: 36558421 Free PMC article.
-
Glucocorticosteroids for people with alcoholic hepatitis.Cochrane Database Syst Rev. 2017 Nov 2;11(11):CD001511. doi: 10.1002/14651858.CD001511.pub3. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2019 Apr 09;4:CD001511. doi: 10.1002/14651858.CD001511.pub4. PMID: 29096421 Free PMC article. Updated.
-
Nutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysis.Cochrane Database Syst Rev. 2021 Jul 19;7(7):CD013157. doi: 10.1002/14651858.CD013157.pub2. Cochrane Database Syst Rev. 2021. PMID: 34280304 Free PMC article.
-
Ultra-processed foods and non-alcoholic fatty liver disease: an updated systematic review and dose-response meta-analysis.Front Nutr. 2025 Jul 11;12:1631975. doi: 10.3389/fnut.2025.1631975. eCollection 2025. Front Nutr. 2025. PMID: 40717999 Free PMC article.
-
Nutritional labelling for healthier food or non-alcoholic drink purchasing and consumption.Cochrane Database Syst Rev. 2018 Feb 27;2(2):CD009315. doi: 10.1002/14651858.CD009315.pub2. Cochrane Database Syst Rev. 2018. PMID: 29482264 Free PMC article.
References
-
- Carpi RZ, Barbalho SM, Sloan KP, Laurindo LF, Gonzaga HF, Grippa PC, et al. The effects of probiotics, prebiotics and synbiotics in non-alcoholic fat liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): a systematic review. Int J Mol Sci. (2022) 23:8805. doi: 10.3390/ijms23158805, PMID: - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources